Reid Laurence

CIK 00014927494 companiesFRAMINGHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001492749

Recent Transactions

50 trades

Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Stock Option (Right to Buy)
2026-06-11−17,000→ 0 total
Award
Metagenomi Therapeutics, Inc.$MGX
Stock Option (Right to Buy)
2026-06-09+17,400→ 17,400 total
Award
Metagenomi Therapeutics, Inc.$MGX
Stock Option (Right to Buy)
2025-09-02+42,000→ 42,000 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Stock Option (Right to Buy)
2024-11-23+17,000→ 17,000 total
Disposition to Issuer
Decibel Therapeutics, Inc.
Stock Option (right to buy)
2023-09-25−187,500→ 0 total
Disposition to Issuer
Decibel Therapeutics, Inc.
Stock Option (right to buy)
2023-09-25−1,072,539→ 0 total
Disposition to Issuer
Decibel Therapeutics, Inc.
Stock Option (right to buy)
2023-09-25−72,000→ 0 total
Disposition to Issuer
Decibel Therapeutics, Inc.
Common Stock
2023-09-25−220,849→ 0 total
Award
Decibel Therapeutics, Inc.
Common Stock
2023-03-16+195,000→ 220,849 total
Award
Decibel Therapeutics, Inc.
Stock Options (right to buy)
2023-03-16+72,000→ 72,000 total
Award
Decibel Therapeutics, Inc.
Stock Options (right to buy)
2022-02-25+187,500→ 187,500 total
Purchase
Decibel Therapeutics, Inc.
Common Stock
2021-09-15$7.64/sh+10,000→ 25,849 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (Right to Buy)
2014-12-31−17,000→ 133,609 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2014-12-31$15.99/sh+17,000→ 20,905 total
Tax Payment
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2014-12-31$97.00/sh−2,802→ 18,103 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Performance Based Stock Option (right to buy)
2014-12-12+6,667→ 6,667 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2014-11-18$90.30/sh−5,413→ 8,492 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2014-11-18$91.08/sh−4,485→ 4,007 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2014-11-18$9.14/sh+3,861→ 10,266 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2014-11-18$15.99/sh+3,639→ 13,905 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (Right to Buy)
2014-11-18−3,861→ 1,728 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (Right to Buy)
2014-11-18−3,639→ 150,609 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2014-11-18$7.10/sh+2,500→ 6,405 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (Right to Buy)
2014-11-18−2,500→ 12,500 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2014-11-18$91.79/sh−102→ 3,905 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2014-08-18$9.14/sh+11,000→ 17,405 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (Right to Buy)
2014-08-18−2,500→ 15,000 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2014-08-18$67.80/sh−7,000→ 3,905 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (Right to Buy)
2014-08-18−11,000→ 5,589 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2014-08-18$7.10/sh+2,500→ 6,405 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2014-08-18$66.83/sh−6,500→ 10,905 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2014-02-19$78.62/sh−3,079→ 21,226 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2014-02-19$80.85/sh−5,456→ 4,305 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2014-02-19$80.02/sh−11,465→ 9,761 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2014-02-19$81.45/sh−400→ 3,905 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2014-02-19−10,000→ 20,000 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2014-02-19−3,500→ 154,248 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2014-02-19$7.10/sh+10,000→ 20,805 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2014-02-19$15.99/sh+3,500→ 24,305 total
Tax Payment
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2014-01-23$89.49/sh−3,698→ 10,805 total
Tax Payment
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2013-12-30$64.51/sh−930→ 14,503 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2013-12-30−3,752→ 157,748 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2013-12-30$15.99/sh+3,752→ 15,433 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2013-12-18+20,000→ 20,000 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2013-11-13$53.36/sh−13,500→ 11,681 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (Right to Buy)
2013-11-13−13,500→ 161,500 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2013-11-13$15.99/sh+13,500→ 25,181 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2013-05-28$30.00/sh−5,000→ 11,681 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2013-05-28$7.10/sh+5,000→ 16,681 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (Right to Buy)
2013-05-28−5,000→ 30,000 total

Companies

Recent Filings

Address

C/O KALVISTA PHARMACEUTICALS, INC. 200 CROSSING BOULEVARD

FRAMINGHAM, MA, 01702

View on SEC.gov